Heterozygous mutations in transcription factor gene NKX2‐5 are connected to either isolated or combined congenital heart disease (CHD), primarily secundum atrial septal defect‐II (ASD‐II), ventricular septal defect (VSD) or tetralogy of Fallot (TOF). This evidence concerns the gene NKX2-5 and congenital heart disease.